Key result
Serum lipid levels are linked to distinct whole-blood gene expression across nearly 470 lipid-related genes.
Why the study?
Although blood lipids are established risk factors for cardiovascular and other chronic diseases, the underlying functional mechanisms remain unclear.
Cross-Sectional (n=6,898)
Yes
This multi-ancestry transcriptomic analysis identifies and replicates whole-blood gene expression signatures and causal genetic regulatory mechanisms (such as EEPD1, BRI3, DDAH2, and FCGRT) linked to serum lipid levels and immune regulation, offering novel potential therapeutic targets for dyslipidemia.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications for lipid management; leaves open causal roles of identified transcripts for prospective validation.
Blood lipids are well-established risk factors for cardiovascular and other chronic diseases, yet the underlying functional mechanisms remain unclear. We conducted a large-scale, genome-wide transcriptome analysis of serum lipid levels using whole blood RNA-sequencing data from 6898 individuals of diverse races and ethnicities (17% Black or African American, 15% Hispanic Latino/a, 68% White). We utilized mixed-effects linear regression and meta-analyzed four discovery datasets (n = 4398 participants), identifying significant associations for 27 genes with low-density lipoproteins (LDL), 974 with high-density lipoproteins (HDL), 1229 with triglycerides (TRIG), and 276 with total cholesterol (TCHO). Two replication datasets (n = 2500 participants) confirmed 3, 55, 380, and 31 genes, respectively. Enrichment analysis revealed lipid metabolic processes for LDL, HDL, and TCHO associated genes, including LDLR, NPC2, and SQLE for LDL and TCHO, while TRIG associated genes highlighted immune and allergic response, cancer, and molecular signaling gene enrichment pathways. To infer causality, we performed bidirectional two-sample Mendelian randomization (MR) and colocalization analyses. MR identified the expression of 8 genes as possibly causal for lipid levels; notable EEPD1 expression, linked with cellular cholesterol homeostasis, was inversely linked with TRIG levels. We also identified novel variants shared with LDL levels and gene expression of DDAH2, associated with cardiovascular disease, and TRIG level and expression of FCGRT, linked with maintaining triglyceride homeostasis. Phenome-wide enrichment analyses reported TRIG associated genes were enriched in secondary malignancy of bone suggesting broader systemic health implications of modified lipid levels. These findings highlight novel associations and genetic regulatory mechanisms as potential therapeutic targets for lipid dysregulation.
No takes yet. Share an insight, caveat, or question.
Lundin et al. (2026) conducted a cross-sectional in Dyslipidemia and serum lipid levels (LDL, HDL, triglycerides, total cholesterol) (n=6,898). Serum lipid levels (LDL, HDL, triglycerides, and total cholesterol) was evaluated on Replicated differential gene expression in whole blood white blood cells associated with serum lipid traits (p=<2.38e-6). Serum lipid levels were significantly associated with replicated whole blood gene expression for 3 LDL, 55 HDL, 380 triglyceride, and 31 total cholesterol genes across 6,898 diverse individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: